Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk
Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk
Objective: Primary prevention of cardiovascular disease (CVD) in women is a major healthcare issue. Detection of premenopausal women with increased risk of CVD could enhance prevention strategies and reduce first event-related morbidity and mortality. In this study, we argue that an unfavorable metabolic constitution in women may present itself early in life as a reproductive complication, such as polycystic ovary syndrome (PCOS) and preeclampsia. We evaluated the cardiovascular risk of women with a history of early-onset preeclampsia and women with PCOS and assessed their need for implementation of early risk factor-reduction strategies.
Methods: We performed a standardized evaluation of 240 women with a history of early-onset preeclampsia and 456 women diagnosed with PCOS for established major CVD risk factors. Metabolic syndrome characteristics were analyzed per body mass index category.
Results: Mean age was 30.6 and 29.0 years for women with preeclampsia and PCOS, respectively. High percentages of metabolic syndrome were found in both groups (preeclampsia group, 14.6%; and PCOS group, 18.4%), with an incidence of greater than 50% in both groups of women if body mass index was greater than 30 kg/m. Overall, more than 90% of the women qualified for either lifestyle or medical intervention according to the American Heart Association guideline for CVD prevention in women.
Conclusions: Women with PCOS and early-onset preeclampsia already show an unfavorable cardiovascular risk profile with high need for lifestyle or medical intervention at a young age. We therefore recommend an active role of the gynecologist in routine screening and follow-up of women with reproductive conditions linked to future cardiovascular risk.
990-996
Veltman-Verhulst, Susanne M.
533d90ca-7c43-4fc3-8b25-48ec42d8364d
van Rijn, Bas B.
c958dfb5-2010-46de-a350-4903295ac340
Westerveld, H. Egbertine
34bc56fe-bf27-4729-8510-5f295e419f53
Franx, Arie
2376857f-07db-4821-9512-a7b55036b6f0
Bruinse, Hein W.
9cf35612-505e-4035-a2b8-c63a0ec15421
Fauser, Bart C.J.M.
0edf5e0f-12db-4ca9-bf9c-00e85b7f4a3e
Goverde, Angelique J.
ca9c43fe-c0fc-4baf-a426-2870ae2d3769
September 2010
Veltman-Verhulst, Susanne M.
533d90ca-7c43-4fc3-8b25-48ec42d8364d
van Rijn, Bas B.
c958dfb5-2010-46de-a350-4903295ac340
Westerveld, H. Egbertine
34bc56fe-bf27-4729-8510-5f295e419f53
Franx, Arie
2376857f-07db-4821-9512-a7b55036b6f0
Bruinse, Hein W.
9cf35612-505e-4035-a2b8-c63a0ec15421
Fauser, Bart C.J.M.
0edf5e0f-12db-4ca9-bf9c-00e85b7f4a3e
Goverde, Angelique J.
ca9c43fe-c0fc-4baf-a426-2870ae2d3769
Veltman-Verhulst, Susanne M., van Rijn, Bas B., Westerveld, H. Egbertine, Franx, Arie, Bruinse, Hein W., Fauser, Bart C.J.M. and Goverde, Angelique J.
(2010)
Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk.
Menopause, 17 (5), .
(doi:10.1097/gme.0b013e3181ddf705).
(PMID:20551845)
Abstract
Objective: Primary prevention of cardiovascular disease (CVD) in women is a major healthcare issue. Detection of premenopausal women with increased risk of CVD could enhance prevention strategies and reduce first event-related morbidity and mortality. In this study, we argue that an unfavorable metabolic constitution in women may present itself early in life as a reproductive complication, such as polycystic ovary syndrome (PCOS) and preeclampsia. We evaluated the cardiovascular risk of women with a history of early-onset preeclampsia and women with PCOS and assessed their need for implementation of early risk factor-reduction strategies.
Methods: We performed a standardized evaluation of 240 women with a history of early-onset preeclampsia and 456 women diagnosed with PCOS for established major CVD risk factors. Metabolic syndrome characteristics were analyzed per body mass index category.
Results: Mean age was 30.6 and 29.0 years for women with preeclampsia and PCOS, respectively. High percentages of metabolic syndrome were found in both groups (preeclampsia group, 14.6%; and PCOS group, 18.4%), with an incidence of greater than 50% in both groups of women if body mass index was greater than 30 kg/m. Overall, more than 90% of the women qualified for either lifestyle or medical intervention according to the American Heart Association guideline for CVD prevention in women.
Conclusions: Women with PCOS and early-onset preeclampsia already show an unfavorable cardiovascular risk profile with high need for lifestyle or medical intervention at a young age. We therefore recommend an active role of the gynecologist in routine screening and follow-up of women with reproductive conditions linked to future cardiovascular risk.
This record has no associated files available for download.
More information
Published date: September 2010
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 352046
URI: http://eprints.soton.ac.uk/id/eprint/352046
ISSN: 1072-3714
PURE UUID: 60c6487e-6649-457d-af46-c28edceb6724
Catalogue record
Date deposited: 01 May 2013 12:20
Last modified: 14 Mar 2024 13:46
Export record
Altmetrics
Contributors
Author:
Susanne M. Veltman-Verhulst
Author:
Bas B. van Rijn
Author:
H. Egbertine Westerveld
Author:
Arie Franx
Author:
Hein W. Bruinse
Author:
Bart C.J.M. Fauser
Author:
Angelique J. Goverde
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics